BridgeBio Pharma (BBIO) Tax Rate (2024 - 2025)
BridgeBio Pharma's (BBIO) quarterly Tax Rate came in at 0.06% in Q4 2025, up 49.0% year-on-year from 0.04% in Q4 2024, and down 92.34% quarter-over-quarter from 0.8% in Q3 2025.
BridgeBio Pharma (BBIO) Tax Rate (2024 - 2025) Analysis & Trends
BridgeBio Pharma has disclosed Tax Rate across 2 years of filings, most recently posting 0.06% for Q4 2025.
- Tax Rate for Q4 2025 came in at 0.06%, up 49.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.24% (changed N/A YoY), and the FY2025 annual result was 0.06%, up 15.0% from the prior year.
- Tax Rate came in at 0.06% for Q4 2025 at BridgeBio Pharma, down from 0.8% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.8% in Q3 2025 to a low of 1.16% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BridgeBio Pharma | 12.90 Bn | 11.97 Bn | 184.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.06% |
| Dec 31, 2025 | 0.06% |
| Sep 30, 2025 | 0.80% |
| Sep 30, 2025 | 0.80% |
| Jun 30, 2025 | -1.16% |
| Jun 30, 2025 | -1.16% |
| Dec 31, 2024 | -0.43% |
| Dec 31, 2024 | -0.43% |